advances in molecular neurobiology: neural stem cells and … · 2019. 10. 18. · molecular...

55
Week 4 Molecular mechanisms of synaptic plasticity Advances in Molecular Neurobiology: Neural Stem Cells and Neuroregenerative Approaches

Upload: others

Post on 03-Feb-2021

0 views

Category:

Documents


0 download

TRANSCRIPT

  • Week 4

    Molecular mechanisms of synaptic plasticity

    Advances in Molecular Neurobiology:

    Neural Stem Cells and Neuroregenerative Approaches

  • SYNAPTIC TRANSMISSION-I(Chapter 10)

  • Type of

    Synapse

    Distance btw

    membranes

    Cytoplasmic

    continuity

    Ultrastructural Agents of

    transmission

    Synaptic

    delay

    Direction of

    transmission

    Electrical 3.5 nm Yes Gap-junctions İon current None Bidirectional

    Chemical 20 - 40 nm No Presynaptic

    vesicles; Post-

    synaptic

    receptors

    Chemical

    transmitters

    ~0.3 msec

    to 5 msec

    unidirectional

    PROPERTIES OF ELECTRICAL AND CHEMICAL SYNAPSES

  • Electrical transmission through gap junctions

    Actual physical continuity between the presynaptic and postsynaptic cells.

    The pre- and post-synaptic neurons are joined by gap junctions which are

    formed by hexameric protein subunits known as connexons (also found

    embryos during development, as well as in heart and epithelial cells).

    Each connexon is made up of 6 identical protein subunits called connexins.

    They form very large channels -- 1 to 2 nm -- between the connecting cells, so

    that not only ions but various molecules with MW 's up to about 1500 can pass

    through -- big enough so that substances like cAMP or ion current itself can

    pass through ...

    Amacrine cells in retina, for instance, pass along glycine to photoreceptors

    • Speed

    • Synchrony among cells

    • Metabolic coupling

    Electrical transmission is “graded”, and occurs even when the currents in the “presynaptic cell” are below

    the threshold for action potential....

    Most electrical synapses will transmit both depolarizing and hyperpolarizing currents.

    openclosed

    http://www.williams.edu/williams-only/Neuroscience/courses/Biol304/00lec1/lec7c.gifhttp://www.williams.edu/williams-only/Neuroscience/courses/Biol304/00lec1/lec7c.gif

  • Most gap junctions close in response to :

    1- lowered cytoplasmic pH; or

    2- elevated cytoplasmic Ca++

    These properties are necessary to separate or “decouple” damaged cells from other cells....

    At some specialized gap junctions –

    Voltage-dependent gates that permit them to conduct depolarizing current only from the

    presynaptic to post-synaptic neuron.....

    (rectifying synapses)

    Gap junctions can be found between glial cells as well as neurons......

  • The synapse consists of:

    1. The presynaptic terminal at the end of an axon. This contains tiny vesicles which contain neurotransmitters - the small

    molecules which carry the nerve impulse from the sending neuron to the receiving neuron.

    2. The synaptic cleft - a gap between the two neurons across which the neurotransmitters migrate.

    3. The postsynaptic terminal usually in the dendrites of receiving neurons. This contains receiving sites for the

    neurotransmitters.

    Chemical transmission

  • Ion signaling at nerve endings

    electrical chemical chemical electrical

    Action potentials at the presynaptic axon termini cause

    opening of voltage-gated calcium channels....

    Ca++ influx causes neurotransmitter-containing vesicles to

    fuse with the cell membrane and release their contents.

    Released neurotransmitters diffuse across the synaptic

    cleft and bind receptors on the membrane of the post-

    synaptic neuron. The receptors cause ion channels to

    open or close, depending on the “instruction”.

  • Frog neuromuscular junction as a relatively simple model of

    a chemical synapse.

    A. Ultrastructure:

    Chemical synapses are more complex than gap junctions

    and show a great deal of structural specialization both on the

    presynaptic side of things and on the post-synaptic side of

    things. At the neuromuscular junction:

    The incoming motor nerve loses its myelin sheath and gives

    off branches that run in shallow grooves in the surface of the

    muscle. (Although the Schwann cell still hovers protectively

    around the nerve terminal.)

    In between the nerve terminal and the muscle is the

    synaptic cleft which is a gap about 30 nm wide. So there's a

    significant space between the presynaptic nerve terminal's

    plasma membrane and the post-synaptic muscle's plasma

    membrane.

    In the cleft is the basal lamina, a network of connective

    tissue that follows the contours of the muscle membrane

    (where the AChE is found)

    and on the muscle side are grooves and channels known as

    the post-junctional folds. The acetylcholine receptors are

    found at the outer lips of the post-junctional folds. This whole

    region of the muscle in apposition with the nerve terminal is

    known as the motor endplate.

    Back in the nerve terminal, are mitochondria, which may be

    important in buffering the free calcium concentration under

    certain conditions and synaptic vesicles.

    Active zone

    Active zone : docking and release sites for vesicles

    http://www.williams.edu/williams-only/Neuroscience/courses/Biol304/00lec1/lec7d.gifhttp://www.williams.edu/williams-only/Neuroscience/courses/Biol304/00lec1/lec7d.gif

  • • Fast, electrical response to arrival of

    presynaptic action potential: EPSP, IPSP

    • Use amino acids and amines as

    neurotransmitters

    • Slow, modulatory chemical synapses

    • Slow response to arrival of presynaptic action

    potential, activate second messenger system,

    not always a direct electrical effect

    • May use amino acids, amines, or peptides

  • Upon arrival of an action potential at a synapse:

  • Upon arrival of an action potential at a

    synapse:

    1. Opening of voltage-gated sodium and

    calcium channels

    2. Influx of calcium results in the docking of

    synaptic vesicles at the presynaptic

    membrane

    3. Vesicles and membrane fuse, transmitter

    substance is released into synaptic cleft

    transmitter molecules open ligand-gated

    sodium channels in the postsynatic

    membrane.

    4. Small changes of potential occur locally -

    these events are called e.g. excitatory

    postsynaptic potentials (epsps).

    Epsps summate (add together) when there

    are enough synapses near together.

    This is called spatial summation.

    5. When the postsynatic membrane is

    depolarized in rapid succession, epsps also

    add to provide temporal summation.

    6. Spatial or temporal summation can

    produce an action potential in the next

    neuron.

  • Neurotransmitters are additive –

    if the net effect of all the excitory neurotransmitters minus all the inhibitory ones achieves this threshold

    =

    then an action potential will be initiated.

  • Question: What happens if a large EPSP is "summed" with an equally large IPSP?

    If a neurotransmitter binds to an ion channel, that channel may open up.

    Let's say two different neurotransmitters are floating around in the synapse, and one of them causes a

    Na+ channel to open and Na+ is drawn into the cell by both electrical and concentration forces.

    The other neurotransmitter affects a different ion channel, let's say it causes a Cl- ion channel to open,

    and Cl-is drawn into the cell by concentration forces.

    Na+ entering the cell causes the cell to become more positive (or less polarized since the resting

    membrane potential is negative) which is refered to as a depolarization. Cl- entering the cell would

    cause an already negative membrane potential to become even more negative, this is refered to as a

    hyperpolarization.

    Back to the original question, if these events were to happen simultaneously (Na+ moves into the

    cell, while Cl- does the same) the net effect is no change in membrane potential, and thus no action

    potential will occur.

    The important point here is that the generation of an action potential does not depend on single,

    independent inputs on the dendrites. Rather, the generation of an action potential depends on the

    summation of multiple inputs distributed over the network of dendrites.

    Answer: They cancel one another out.

  • •Small molecule transmitters - amino acids and amines

    •Examples of amino acid neurotransmitters - gamma-amino butyric acid (GABA),

    glutamate (Glu), glycine (Gly)

    •Examples of amine neurotransmitters - acetylcholine (ACh), dopamine (DA),

    epinephrine, histamine, norepinephrine (NE), serotonin (5-HT)

    •Synthesis occurs in axon terminal

    •Precursor molecule is transformed by synthetic enzyme into neurotransmitter molecule

    •Neurotransmitter molecules are gathered by transporter molecules and packaged in

    synaptic vesicles

    glycine

    dopamine

    serotonin

    acetylcholine

    epinephrine

    http://webvision.med.utah.edu/imageswv/GLU1.jpeghttp://webvision.med.utah.edu/imageswv/GLU1.jpeghttp://www.psychiatry.co.uk/doxepine/index.htmlhttp://www.psychiatry.co.uk/doxepine/index.htmlhttp://www.psychiatry.co.uk/doxepine/index.htmlhttp://www.psychiatry.co.uk/doxepine/index.htmlhttp://www.psychopharmacology.net/sertraline/index.htmlhttp://www.psychopharmacology.net/sertraline/index.html

  • • Large molecule transmitters - peptides Examples - substance P,

    somatostatin, leu-enkephalin, met- enkephalin, vasoactive

    intestinal polypeptide (VIP), bombesin

    • Occurs in soma, secretory vesicles transported down axon by

    orthograde axonal transport

    • Peptide synthesized in rough endoplasmic reticulum

    • Packaged in Golgi apparatus

    • Transported down axon to presynaptic ending of axon terminal

    Neuropeptide

    neurotransmitters

    Corticotropin releasing

    hormone

    Corticotropin (ACTH)

    Beta-endorphin

    Substance P

    Neurotensin

    Somatostatin

    Bradykinin

    Vasopressin

    Angiotensin II

    the arginine vasopressin (AVP)

    polypeptide that is comprised of

    9 amino acids

  • Small molecule neurotransmitters

    Type Neurotransmitter Postsynaptic effect

    Acetylcholine Excitatory

    Amino acids Gamma aminobutyric acid (GABA) Inhibitory

    Glycine Inhibitory

    Glutamate Excitatory

    Aspartate Excitatory

    Biogenic amines Dopamine Excitatory

    Noradrenaline Excitatory

    Serotonin Excitatory

    Histamine Excitatory

  • Neurotransmitter synthesis in the axon terminals – Acetylcholine synthesis

    acetylcholine

  • Schematic diagram of the nAChR showing the arrangement of

    subunits and a cross-sectional representation of the protein

    Acetylcholine and glutamate are examples of excitatory

    neurotransmitters…

    The ligand-gated ion channels differ from voltage-gated

    ion channels in that they are activated by binding of

    neurotransmitters.

    In addition, they also differ in terms of selective ion

    permeability.

    Upon activation and channel opening, both Na+ and K+

    can flow through the channel.

    At first this might seem to exert no net effect on a

    neuron, due to the counterbalancing effects of Na+

    influx and K+ efflux.

    Based on the resting membrane potential (near -70

    mV) and the equilibrium potentials for each ion

    however, we can see that there is a tremendous

    potential difference for Na+, yet a very small differential

    for K+.

    As a result, at rest, acetylcholine triggers a rapid influx

    of Na+. This influx of Na+ leads to an excitatory

    postsynaptic potential (epsp).

  • Muscarinic acetylcholine receptor

    Muscarinic receptors can exert multiple actions upon a neuron,

    depending upon the subtypes of receptor, G proteins, and target

    proteins.

    For example, in the CNS, activation of M1 receptors, generally

    postsynaptic, leads to an increase in phospholipase C activity via Gaq.

    This in turn leads to the formation of 1,2-diacylglycerol and inositol

    triphosphate. 1,2-Diacylglycerol stimulates protein kinase C activity,

    which leads to phosphorlyation of intracellular proteins.

    In addition, IP3 generation leads to mobilization of Ca2+ from

    intracellular stores.

    Increases in Ca2+ can enhance the release of neurotransmitters and

    activate calmodulin.

    Activation of M2 receptors, which have been found on presynaptic

    neurons, leads to the opening of potassium channels, which tends to

    hyperpolarize the cell and prevent neurotransmitter release.

  • G-protein coupled receptor (GPCR) signaling

  • g-amino butyric acid

  • Neurotransmitter reuptake

    represents an important

    mechanism for inactivating

    neurotransmitters.

    Specific transporter proteins

    have been identified for several

    neurotransmitters, including

    GABA, glycine, dopamine, and

    serotonin.

    A number of neuroactive drugs

    exert their action through

    inhibition of neurotransmitter

    reuptake.

    For example, cocaine strongly

    inhibits the dopamine reuptake

    mechanism, while fluoxetine

    (Prozac®) blocks the uptake of

    serotonin, thereby exerting an

    antidepressant effect.

  • Glutamate is the major excitatory neurotransmitter in central

    nervous system (CNS) and as such the glutamate receptors

    play a vital role in the mediation of excitatory synaptic

    transmission (see animation). This process is the means by

    which cells in the brain (neurons) communicate with each other.

    An electrical impulse in one cell causes an influx of calcium ions

    and the subsequent release of a chemical neurotransmitter (e.g.

    glutamate). The transmitter diffuses across a small gap between

    two cells (the synaptic cleft) and stimulates (or inhibits) the next

    cell in the chain by interacting with receptor proteins. The

    specialised structure that performs this vital function is the

    synapse and it is in the synapse that the ionotropic glutamate

    receptors are generally found.

    The ionotropic receptors themselves are ligand gated ion

    channels, ie on binding glutamate that has been released from

    a companion cell, charged ions such as Na+ and Ca2+ pass

    through a channel in the centre of the receptor complex. This

    flow of ions results in a depolarisation of the plasma membrane

    and the generation of an electrical current that is propagated

    down the processes (dendrites and axons) of the neuron to the

    next in line.

  • The NMDA receptor (NMDAR) is an ionotropic receptor for glutamate (NMDA (N-methyl d-aspartate) is a

    name of its selective specific agonist). Activation of NMDA receptors results in the opening of an ion

    channel which is nonselective to cations. This allows flow of Na+ and K+ ions, and small amounts of Ca2+ .

    Calcium flux through NMDARs is thought to play a critical role in synaptic plasticity, a cellular mechanism

    for learning and memory.

    The NMDA receptor is interesting in that it is both ligand-gated and voltage-dependent.

  • Activation of NMDA receptors requires binding of both glutamate and the co-agonist glycine for the

    efficient opening of the ion channel which is a part of this receptor.

    D-serine has also been found to co-agonize the NMDA receptor with even greater potency than glycine.

    D-serine is produced by serine racemase in astrocyte cells and is enriched in the same areas as NMDA

    receptors. Removal of D-serine can block NMDA mediated excitatory neurotransmission in many areas.

    Recently, it has been shown that D-serine is also synthesized in neurons, indicating a role for neuron-

    derived D-serine in NMDA receptor regulation.

    In addition, a third requirement is membrane depolarization. A positive change in transmembrane

    potential will make it more likely that the ion channel in the NMDA receptor will open by expelling the

    Mg2+ ion that blocks the channel from the outside.

  • Dopamine receptors are a class of metabotropic G protein-coupled

    receptors that are prominent in the vertebrate central nervous system.

    The neurotransmitter dopamineis the endogenous ligand for dopamine

    receptors.

    http://en.wikipedia.org/wiki/Dopamine

  • Noradrenaline (norepinephrine) receptors are G-protein coupled

  • Noradrenaline

    Receptor TypeDistribution Postulated Roles

    Alpha1 Brain, heart, smooth muscle Vasoconstriction, smooth muscle control

    Alpha2 Brain, pancreas, smooth muscle Vasoconstriction, presynaptic effect in GI

    (relaxant)

    Beta1 Heart, brain Heart rate (increase)

    Beta2 Lungs, brain, skeletal muscle Bronchial relaxation, vasodilatation

    Beta3 Postsynaptic effector cells Stimulation of effector cells

  • Receptor

    TypeDistribution Postulated Roles

    5-HT1 Brain, instetinal nerves Neuronal inhibition, behavioural effects, cerebral

    vasoconstriction

    5-HT2 Brain, heart, lungs, smooth muscle control, GI

    system, blood vessels, platelets

    Neuronal excitation, vasoconstriction, behavioural

    effects, depression, anxiety

    5-HT3 Limbic system, ANS Nausea, anxiety

    5-HT4 CNS, smooth muscle Neuronal excitation, GI

    5-HT5, 6,

    7

    Brain Not known

  • Modulation of Synaptic

    Transmission

    (Chapter 13)

  • 1. DIRECT GATING (Ionotropic Receptor) 2. INDIRECT GATING

    a) G protein-coupled receptor

    b) Receptor Tyrosine kinase

  • G proteins are so-called because they bind the guanine

    nucleotides GDP and GTP.

    They are heterotrimers (i.e., made of three different subunits)

    associated with:

    •the inner surface of the plasma membrane and

    •transmembrane receptors of hormones, etc.

    •These are called G protein-coupled receptors (GPCRs).

    The three subunits are:

    •Gα, which carries the binding site for the nucleotide.

    (At least 20 different kinds of Gα molecules are

    found in mammalian cells)

    •Gβ

    •Gγ

  • Protein Kinase A (cAMP-Dependent Protein Kinase) transfers Pi from ATP to the hydroxyl group of a

    serine or threonine that is part of a particular 5-amino acid sequence. Protein Kinase A exists in the

    resting state as a complex of:

    •2 regulatory subunits (R)

    •2 catalytic subunits (C)

    Each regulatory subunit (R) of Protein Kinase A contains a pseudosubstrate sequence comparable to

    the substrate domain of a target protein for Protein Kinase A, but with alanine substituting for the serine

    or threonine. The pseudosubstrate domain of the regulatory subunit, which lacks a hydroxyl that can be

    phosphorylated, binds to the active site of the catalytic subunit, blocking its activity.

    When each regulatory subunit binds 2

    cAMP, a conformational change

    causes the regulatory subunits to

    release the catalytic subunits. The

    catalytic subunits (C) can then

    catalyze phosphorylation of serine or

    threonine residues on target proteins.

    R2C2 + 4 cAMP R2cAMP4 + 2 C

    PKIs, Protein Kinase Inhibitors,

    modulate activity of the catalytic

    subunits (C).

  • Some Types of Gα Subunits

    Gαs

    This type stimulates (s = "stimulatory") adenylyl cyclase. It is associated with the receptors for many

    hormones such as adrenaline or adrenocorticotropic hormone (ACTH).

    Gαq

    This activates phospholipase C (PLC) which generates the second messengers inositol trisphosphate (IP3)

    and diacylglycerol (DAG).

    Gαq is found in G proteins coupled to receptors for vasopressin and angiotensin.

    Gαi

    This inhibits (i = "inhibitory") adenylyl cyclase lowering the level of cAMP in the cell. Gai is activated by

    the receptor for somatostatin.

    Gαt

    The "t" is for transducin, the molecule responsible for generating a signal in the rods of the retina in

    response to light. Gαt triggers the breakdown of cyclic GMP (cGMP).

  • Secondary Messengers - cAMP

  • Secondary messengers “relay” the incoming signal to the nucleus or cytoplasm

    and generate a response in the cell.....

  • Secondary Messengers – Ca++

  • SYNAPTIC INTEGRATION

  • Nerve impulses are transmitted down to the presynaptic terminal in the axon of

    one neuron and across the synaptic cleft to the postsynaptic terminal in the

    dendrite of another neuron.

    Synapses do not only join axons to dendrites (axodendritic synapses) –

    they can also joins axons to other axons (axoaxonic synapses) –

    or to the soma - the neuronal cell body - (axosomatic synapses).

  • Temporal summation

  • Spatial summation

  • Shunting inhibition

  • Drug Action

  • Nicotine action on synaptic transmission

    Nicotine works by docking to a subset of receptors that bind the neurotransmitter acetylcholine.

    Acetylcholine is the neurotransmitter that (depending on what region of the brain a neuron is in):

    - Delivers signals from your brain to your muscles

    - Controls basic functions like your energy level, the beating of your heart and how you breathe

    - Acts as a "traffic cop" overseeing the flow of information in your brain

    - Plays a role in learning and memory

  • One of the neurotransmitters playing a major role in addiction is dopamine. Many of the

    concepts that apply to dopamine apply to other neurotransmitters as well.

    As a chemical messenger, dopamine is similar to adrenaline. Dopamine affects brain

    processes that control movement, emotional response, and ability to experience

    pleasure and pain.

    Some drugs are known as dopamine agonists. These drugs bind to

    dopamine receptors in place of dopamine and directly stimulate those

    receptors. Some dopamine agonists are currently used to treat Parkinson's

    disease. These drugs can stimulate dopamine receptors even in someone

    without dopamine neurons.

    In contrast to dopamine agonists, dopamine antagonists are drugs that

    bind but don't stimulate dopamine receptors. Antagonists can prevent or

    reverse the actions of dopamine by keeping dopamine from attaching to

    receptors.

  • One important aspect of drug addiction is how cells adapt to

    previous drug exposure.

    For example, long-term treatment with dopamine antagonists

    increases the number of dopamine receptors. This happens as

    the nervous system tries to make up for less stimulation of the

    receptors by dopamine itself.

    Likewise, the receptors themselves become more sensitive to

    dopamine. Both are examples of the same process, called

    sensitization.

    An opposite effect occurs after dopamine or dopamine agonists

    repeatedly stimulate dopamine receptors.

    Here overstimulation decreases the number of receptors, and the

    remaining receptors become less sensitive to dopamine. This

    process is called desensitization.

    Desensitization is better known as tolerance, where exposure to a

    drug causes less response than previously caused.

  • Caffeine

    Caffeine is an addictive drug. Among its many actions, it operates using the same mechanisms that

    amphetamines, cocaine, and heroin use to stimulate the brain.

    On a spectrum, caffeine's effects are more mild than amphetamines, cocaine and heroin, but it is

    manipulating the same channels, and that is one of the things that gives caffeine its addictive qualities.

    cocaine

    Cocaine prevents dopamine reuptake by binding to proteins that normally transport dopamine. Not only

    does cocaine "bully" dopamine out of the way – it also hangs on to the transport proteins much longer than

    dopamine does.

    As a result, more dopamine remains to stimulate neurons, which causes a prolonged feelings of pleasure

    and excitement. Amphetamine also increases dopamine levels. Again, the result is over-stimulation of

    these pleasure-pathway nerves in the brain.

    http://www.erowid.org/chemicals/caffeine/images/archive/caffeine_3d.jpghttp://www.erowid.org/chemicals/caffeine/images/archive/caffeine_3d.jpghttp://en.wikipedia.org/wiki/Image:Cocaine.pnghttp://en.wikipedia.org/wiki/Image:Cocaine.png

  • (NIH – NIDA)